DR REDDYS LABORATORIES LTD (RDY) Form 6-K — Oct 23, 2026
Dr. Reddy's Laboratories announced the appointment of Akhil Ravi as Head API and Services and a Senior Management Personnel, effective November 13, 2026, following board approval on October 23, 2026. Ravi will continue as CEO of Aurigene Pharmaceutical Services, the company's wholly owned CRDMO subsidiary, which he has led since joining in 2018. The disclosure notes that Ravi is a related party, being the son-in-law of Co-Chairman and Managing Director G V Prasad, a detail disclosed under SEBI Regulation 30 requirements.
Key figures
- Effective Date
- November 13, 2026
- Joined Dr Reddys
- 2018
- Akhil Ravi Years Experience
- nearly 19 years
- Aurigene Ai Share Of Discovery Business
- approximately 30%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.